BRCA1 and Alzheimer disease: It also demonstrates decreased expression of IRIS-1 and 2 in neurons of individuals with AD and T2D, pointing to a link between aberrant expression of IRIS isoforms and deficiencies in neurotransmitter release in patients with AD.